|本期目录/Table of Contents|

[1]蒋之胜,胡力文,丛壮壮,等.术前联合检测肿瘤标志物在预测食管癌预后中的意义[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):461-467.[doi:10.3969/j.issn.1672-271X.2020.05.003]
　JIANG Zhi-sheng,HU Li-wen,CONG Zhuang-zhuang,et al.The significance of preoperative combined detection of tumor markers in predicting the prognosis of esophageal cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(5):461-467.[doi:10.3969/j.issn.1672-271X.2020.05.003]
点击复制

术前联合检测肿瘤标志物在预测食管癌预后中的意义()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第22卷
期数:
2020年5期
页码:
461-467
栏目:
临床研究
出版日期:
2020-09-09

文章信息/Info

Title:
The significance of preoperative combined detection of tumor markers in predicting the prognosis of esophageal cancer
作者:
蒋之胜; 胡力文; 丛壮壮; 周海; 刘开超; 王高明; 申翼
作者单位：233030 蚌埠，蚌埠医学院研究生院（蒋之胜）；210002南京，东部战区总医院（原南京军区南京总医院）心胸外科（胡力文、丛壮壮、周海、刘开超、王高明、申翼）
Author(s):
JIANG Zhi-sheng1; HU Li-wen2; CONG Zhuang-zhuang2; ZHOU Hai2; LIU Kai-chao2; WANG Gao-ming2; SHEN Yi2
(1.Graduate School，Bengbu Medical College，Bengbu 233030，Anhui，China; 2.Department of Cardiothoracic Surgery, General Hospital of Eastern Theater Command，PLA，Nanjing 210002，Jiangsu，China)
关键词:
食管癌; 肿瘤标志物; 联合预测; 生存预后
Keywords:
esophageal cancer; tumor markers; combined prediction; survival prognosis
分类号:
R655.4
DOI:
10.3969/j.issn.1672-271X.2020.05.003
文献标志码:
A
摘要:
目的探讨术前联合检测肿瘤标志物血清水平对食管癌患者术后预后的评估意义。方法回顾性分析2014年1月至2016年12月于东部战区总医院心胸外科行食管癌根治术的276例患者临床资料并进行随访。分析术前性别、年龄、体重指数（BMI）、肿瘤标志物甲胎蛋白（AFP）、癌胚抗原（CEA）、糖类抗原19-9（CA19-9）、鳞状细胞癌抗原（SCC）、Cyfra21-1血清水平及术后食管癌浸润深度、淋巴结转移、临床TNM分期、肿瘤最大直径与食管癌患者生存预后的关系；使用Kaplan-Meier法和ROC曲线分析术前联合检测肿瘤标志物对食管癌患者术后预后的评估能力。结果食管癌浸润深度、淋巴结转移、细胞分化、临床TNM分期、肿瘤最大直径与食管癌患者生存预后有关（P<0.05）。肿瘤标志物SCC、Cycra21-1血清水平均与术后临床TNM分期呈正相关关系（r=0.211,P<0.01；r=0.121,P<0.05）。SCC（P<0.001）、Cyfra21-1（P=0.001）、细胞分化（P=0.001）、TNM分期（P<0.001）是食管癌患者术后预后的独立危险因素。术前联合检测肿瘤标志物（SCC+Cyfra21-1）对食管癌患者术后预后预测的线下面积（AUC=0.707，P<0.001）优于单个指标，且略低于TNM分期（AUC=0.751，P<0.001）。结论术前联合检测肿瘤标志物（SCC+Cyfra21-1）对食管癌术后患者生存预测具有较高的敏感性，可作为食管癌预后预测的潜在标志物。
Abstract:
ObjectiveThe significance of preoperative combined detection of serum level of tumor markers in evaluating the prognosis of patients with esophageal cancer was discussed.MethodsRetrospective analysis was performed on the clinical data of 276 patients who underwent radical resection of esophageal cancer in the Department of Cardiothoracic Surgery of the General Hospital of the Eastern Theater Command from January 2014 to December 2016, and followed up. Analysis of preoperative gender, age, body mass index (BMI), the tumor markers alpha-fetoprotein (AFP) , carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), squamous cell carcinoma antigen (SCC), Cyfra21-1 serum levels, postoperative depth of invasion, lymph node metastasis, clinical TNM stage, maximum tumor diameter and postoperative survival prognosis of esophageal cancer patients, Kaplan-Meier method and ROC curve were used to analyze the ability of preoperative combined detection of tumor markers to evaluate postoperative prognosis of patients with esophageal cancer.ResultsDepth of invasion, lymph node metastasis, cell differentiation, clinical TNM stage, and the maximum tumor diameter were related to the survival and prognosis of patients with esophageal cancer (P<0.05). The serum levels of preoperative tumor markers SCC and cycra21-1 were positively correlated with postoperative clinical TNM staging （r=0.211, P<0.01; r=0.121, P<0.05）. SCC（P<0.001）, Cyfra21-1（P=0.001）, cell differentiation（P=0.001） and TNM stage（P<0.001） were independent risk factors for postoperative prognosis of esophageal cancer patients. Preoperative combined detection of tumor markers (SCC+Cyfra21-1) was better than a single indicator in predicting the prognosis of esophageal cancer patients (AUC=0.707, P<0.001), and slightly lower than TNM stage (AUC=0.751, P<0.001).ConclusionPreoperative combined detection of tumor markers (SCC+Cyfra21-1) is highly sensitive to postoperative survival prediction of patients with esophageal cancer, and can be used as a potential marker for prognosis prediction of esophageal cancer.

参考文献/References:

[1]Bray F,Ferlay J,Soerjomataram I,et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin,2018,68(6):394-424.
[2]孙可欣,郑荣寿,张思维,等.2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤,2019,28(1):4-14.
[3]Chen W,Zheng R,Baade PD,et al. Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[4]中国医师协会胸外科分会快速康复专家委员会. 食管癌加速康复外科技术应用专家共识(2016版)[J]. 中华胸心血管外科杂志,2016,32(12):717-722.
[5]Hou HF,Meng ZX,Zhao Xn,et al. Survival of Esophageal Cancer in China: A Pooled Analysis on Hospital-Based Studies From 2000 to 2018[J]. Front Oncol,2019,9:548.
[6]Ni XG,Bai XF,Mao YL,et al. The clinical value of serum CEA,CA19-9,and CA242 in the diagnosis and prognosis of pancreatic cancer[J].Eur J Surg Oncol,2005,31(2): 164-169.
[7]Nakai Y,Isayama H,Sasaki T,et al. A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer[J].Cancer Chemother Pharmacol,2013,72(6): 1291-1297.
[8]钟英,孙建鹰,杜明华.PTN、Cyfra21-l和CEA联合检测对肺癌诊断的研究[J].医学研究生学报,2009,22(12):1281-1283.
[9]张胜强,崔虎军,郭建宇,等联合检测食管癌手术患者CTCs、CEA、Scc和CA199的临床意义[J].当代医学,2019,25(20):118-119.
[10]张静.多项肿瘤标志物联合检测在食管癌诊断中的应用价值[J].中国卫生检验杂志,2020,30(3):313-315.
[11]Cao X,Zhang L,Feng GR,et al. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage Ⅱ esophageal squamous cell carcinoma[J]. J Transl Med,2012,10(1):197.
[12]Nomura M,Shitara K,Kodaira T,et al. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy[J].Int J Radiat Oncol Biol Phys,2012,82(2): 946-952.
[13]Kato H,Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma[J]. Cancer,1977,40(4):1621-1628.
[14]Kubik S,Moszynska-Zielinska M,Fijuth J,et al. Assessment of the relationship between serum squamous cell carcinoma antigen (SCC-Ag) concentration in patients with locally advanced squamous cell carcinoma of the uterine cervix and the risk of relapse[J].Prz Menopauzalny,2019,18(1): 23-26.
[15]王微微,林凯璇,张承,等.鳞状细胞癌抗原在宫颈鳞癌中的临床应用及研究进展[J].东南国防医药,2017,19(2):179-182.
[16]Sunpaweravong S,Puttawibul P,Sunpaweravong P,et al. Correlation between Serum SCCA and CYFRA 2 1-1,Tissue Ki-67,and Clinicopathological Factors in Patients with Esophageal Squamous Cell Carcinoma[J].J Med Assoc Thai,2016,99(3):331-337.
[17]Kosugi S,Nishimaki T,Kanda T,et al. Clinical Significance of Serum Carcinoembryonic Antigen,Carbohydrate Antigen 19-9,and Squamous Cell Carcinoma Antigen Levels in Esophageal Cancer Patients[J]. World J Surg，2004,28(7):680-685.
[18]Lacroix M.Significance,detection and markers of disseminated breast cancer cells[J].Endocr Relat Cancer,2006,13(4): 1033-1067.
[19]Holdenrieder S,Wehnl B,Hettwer K,et al. Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis[J]. Br J Cancer,2017,116(8):1037-1045.
[20]Di Gioia D,Blankenburg I,Nagel D,et al. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125,CYFRA 21-1,HER2 shed antigen,LDH and CRP in combination with CEA and CA 15-3[J]. Clin Chim Acta,2016,461:1-7.
[21]Chang CC,Yang SH,Chien CC,et al. Clinical meaning of age-related expression of fecal cytokeratin19 in colorectal malignancy[J]. BMC Cancer,2009,9:376.
[22]Blankenburg F,Hatz R,Nagel D,et al. Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer[J]. Tumor Biol,2008,29(4):272-277.
[23]Shi J,Sugrue SP. Dissection of Protein Linkage between Keratins and Pinin,a Protein with Dual Location at Desmosome-Intermediate Filament Complex and in the Nucleus[J]. J Biol Chem,2000,275(20):14910-14915.
[24]Yamamoto K,Oka M,Hayashi H,et al. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma[J]. Cancer,1997,79(9):1647-1616.

相似文献/References:

[1]邓 兰,马春曦,彭国林,等.食管癌放射治疗CT模拟定位[J].医学研究与战创伤救治(原医学研究生学报),2013,15(03):244.[doi:10.3969/j.issn.1672-271X.2013.03.012]
　DENG Lan,MA Chun-xi,PENG Guo-lin,et al.CT simulation in radiotherapy for esophageal carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(5):244.[doi:10.3969/j.issn.1672-271X.2013.03.012]
[2]高 翔,易 俊.机械吻合术在食管癌根治颈部吻合术中的应用[J].医学研究与战创伤救治(原医学研究生学报),2013,15(03):237.[doi:10.3969/j.issn.1672-271X.2013.03.031]
[3]丁海敬.老年食管癌患者自杀未遂1例的护理[J].医学研究与战创伤救治(原医学研究生学报),2013,15(03):312.[doi:10.3969/j.issn.1672-271X.2013.03.033]
[4]邵明永,丁庆莉,高 纯,等.CA125和CA153联合检测对乳腺癌的诊治价值[J].医学研究与战创伤救治(原医学研究生学报),2013,15(05):433.[doi:10.3969/j.issn.1672-271X.2013.05.001]
　SHAO Ming-yong,DING Qing-li,GAO Chun,et al.Roles of detection of CA125 and CA153 in diagnosis and therapy of breast cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(5):433.[doi:10.3969/j.issn.1672-271X.2013.05.001]
[5]郑大东,钟 勇.肿瘤标志物及PET未见异常的肺癌1例[J].医学研究与战创伤救治(原医学研究生学报),2012,14(01):70.
[6]王国洪,陈芳芳,刘国瑞,等.液态芯片技术测定肿瘤标志物的可行性评价[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):395.
[7]周宜勇,张绍明,段德溥,等.高龄食管癌两种手术方式的临床分析[J].医学研究与战创伤救治(原医学研究生学报),2011,13(05):425.
　ZHOU Yi-yong,ZHANG Shao-ming,DUAN De-pu,et al.Elderly esophageal cancer clinical analysis of two surgical methods[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(5):425.
[8]姚运红.食管癌根治术后早期内心体验的质性研究[J].医学研究与战创伤救治(原医学研究生学报),2009,11(02):165.
[9]刘 冉,尹立红,浦跃朴,等.食管组织中代谢酶相关基因的异常表达与 食管癌的发病关系研究[J].医学研究与战创伤救治(原医学研究生学报),2008,10(06):401.
　LIU Ran,YIN Li-hong,PU Yue-pu,et al.Association between metabolism gene expression in esophageal tissues and the risk for esophageal carcinomas[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(5):401.
[10]蔡艺玲,徐文娟,刘 妍,等.新型双层食管支架治疗6例晚期食管癌并梗阻的应用体会[J].医学研究与战创伤救治(原医学研究生学报),2016,18(03):256.[doi:10.3969/j.issn.1672-271X.2016.03.010]
　CAI Yi-ling,XU Wen-juan,LIU Yan,et al.Experience in the treatment of6 cases of advanced esophageal carcinoma with novel double-layered esophageal stent[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(5):256.[doi:10.3969/j.issn.1672-271X.2016.03.010]

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（81702444）；江苏省自然科学基金（BK20160606）
更新日期/Last Update: 2020-09-09